Analysis: Sanofi’s COVID-19 vaccine setback, drug pipeline cast long shadow – Reuters
PARIS, Aug 5 (Reuters) – Pharmaceutical company Sanofi (SASY.PA) remains under pressure to launch new drugs and overcome setbacks in the COVID-19 vaccine race, despite a $3.2 billion deal to tighten its grip on promising mRNA technology.
On Tuesday, Sanofi…
